HK Stock MarketDetailed Quotes

02252 MEDBOT-B

Watchlist
  • 13.480
  • +0.840+6.65%
Not Open Oct 4 16:08 CST
13.10BMarket Cap-15933P/E (TTM)

MEDBOT-B Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(Q3)Mar 31, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
Turnover
108.47%99.24M
384.15%104.59M
4,442.27%47.6M
904.79%21.6M
--1.05M
--2.15M
----
----
----
----
Operating income
108.47%99.24M
384.15%104.59M
4,442.27%47.6M
904.79%21.6M
1.05M
2.15M
Cost of sales
-104.52%-52.22M
-497.69%-89.9M
-7,052.66%-25.54M
-1,121.85%-15.04M
---357K
---1.23M
----
----
----
----
Operating expenses
-104.52%-52.22M
-497.69%-89.9M
-7,052.66%-25.54M
-1,121.85%-15.04M
-357K
-1.23M
Gross profit
113.04%47.01M
123.93%14.69M
3,093.63%22.07M
614.04%6.56M
691K
919K
Selling expenses
27.33%-92.22M
-29.55%-238.43M
-97.80%-126.91M
-132.41%-184.04M
-337.74%-64.16M
-2,840.51%-79.19M
-1,602.32%-14.66M
-847.92%-4.1M
---2.69M
---861K
Administrative expenses
61.25%-30.07M
25.88%-126.36M
-19.13%-77.6M
-58.61%-170.47M
-24.14%-65.14M
-299.78%-107.48M
-541.45%-52.47M
-374.87%-25.09M
-152.15%-26.88M
---8.18M
Research and development expenses
47.34%-164.15M
24.69%-569.18M
7.35%-311.7M
-92.49%-755.8M
-110.16%-336.41M
-190.04%-392.65M
-294.82%-160.07M
-387.61%-90.07M
-118.77%-135.38M
---40.54M
Revaluation surplus
-445.04%-10.44M
-57.59%-42.53M
-120.12%-1.92M
-159.28%-26.98M
283.31%9.53M
1,500.71%45.52M
---5.2M
---2.14M
---3.25M
----
-Changes in the fair value of financial assets
----
-57.59%-42.53M
----
---26.98M
283.31%9.53M
----
---5.2M
----
---3.25M
----
-Changes in the fair value of other assets
-445.04%-10.44M
----
---1.92M
----
----
--45.52M
----
---2.14M
----
----
Special items of operating profit
122.82%5.3M
-137.61%-13.34M
-248.11%-23.21M
288.47%35.48M
1,492.89%15.67M
-292.52%-18.82M
19.85%984K
1,350.82%9.74M
198.72%9.78M
--821K
Operating profit
52.90%-244.58M
10.97%-975.14M
-18.06%-519.26M
-98.53%-1.1B
-90.06%-439.82M
-248.23%-551.7M
-374.56%-231.41M
-374.83%-111.66M
-128.71%-158.43M
-48.76M
Financing cost
-14.04%-9.83M
-63.56%-18.59M
-55.15%-8.62M
-109.13%-11.37M
-688.37%-5.56M
88.95%-5.44M
-247.29%-705K
-162.50%-273K
-9,163.09%-49.19M
---203K
Special items of earning before tax
-51.59%-25.54M
24.84%-29.8M
7.04%-16.85M
-44.85%-39.66M
-73.54%-18.12M
-1,534.45%-27.38M
---10.44M
---2.84M
---1.68M
----
Earning before tax
48.61%-279.95M
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
After-tax profit from continuing operations
48.61%-279.95M
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
Earning after tax
48.61%-279.95M
10.71%-1.02B
-17.53%-544.73M
-96.11%-1.15B
-91.09%-463.5M
-179.28%-584.51M
-395.36%-242.56M
-385.91%-114.77M
-199.84%-209.29M
-48.97M
Minority profit
51.25%-2.79M
-75.30%-11.36M
-28.59%-5.72M
-308.45%-6.48M
-647.73%-4.45M
-281.25%-1.59M
---595K
---362K
---416K
----
Profit attributable to shareholders
48.58%-277.16M
11.20%-1.01B
-17.42%-539.01M
-95.53%-1.14B
-89.72%-459.05M
-179.08%-582.92M
-394.15%-241.97M
-384.37%-114.41M
-199.24%-208.87M
-48.97M
Basic earnings per share
48.21%-0.29
10.92%-1.06
-16.67%-0.56
-88.89%-1.19
-77.78%-0.48
-133.33%-0.63
-285.71%-0.27
-333.33%-0.13
-145.45%-0.27
-0.07
Diluted earnings per share
48.21%-0.29
10.92%-1.06
-16.67%-0.56
-88.89%-1.19
-77.78%-0.48
-133.33%-0.63
-285.71%-0.27
-333.33%-0.13
-145.45%-0.27
-0.07
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
--
Unqualified Opinion
--
Auditor
--
KPMG (Special General Partnership)
--
KPMG (Special General Partnership)
--
KPMG (Special General Partnership)
--
--
KPMG
--
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(Q3)Mar 31, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020
Turnover 108.47%99.24M384.15%104.59M4,442.27%47.6M904.79%21.6M--1.05M--2.15M----------------
Operating income 108.47%99.24M384.15%104.59M4,442.27%47.6M904.79%21.6M1.05M2.15M
Cost of sales -104.52%-52.22M-497.69%-89.9M-7,052.66%-25.54M-1,121.85%-15.04M---357K---1.23M----------------
Operating expenses -104.52%-52.22M-497.69%-89.9M-7,052.66%-25.54M-1,121.85%-15.04M-357K-1.23M
Gross profit 113.04%47.01M123.93%14.69M3,093.63%22.07M614.04%6.56M691K919K
Selling expenses 27.33%-92.22M-29.55%-238.43M-97.80%-126.91M-132.41%-184.04M-337.74%-64.16M-2,840.51%-79.19M-1,602.32%-14.66M-847.92%-4.1M---2.69M---861K
Administrative expenses 61.25%-30.07M25.88%-126.36M-19.13%-77.6M-58.61%-170.47M-24.14%-65.14M-299.78%-107.48M-541.45%-52.47M-374.87%-25.09M-152.15%-26.88M---8.18M
Research and development expenses 47.34%-164.15M24.69%-569.18M7.35%-311.7M-92.49%-755.8M-110.16%-336.41M-190.04%-392.65M-294.82%-160.07M-387.61%-90.07M-118.77%-135.38M---40.54M
Revaluation surplus -445.04%-10.44M-57.59%-42.53M-120.12%-1.92M-159.28%-26.98M283.31%9.53M1,500.71%45.52M---5.2M---2.14M---3.25M----
-Changes in the fair value of financial assets -----57.59%-42.53M-------26.98M283.31%9.53M-------5.2M-------3.25M----
-Changes in the fair value of other assets -445.04%-10.44M-------1.92M----------45.52M-------2.14M--------
Special items of operating profit 122.82%5.3M-137.61%-13.34M-248.11%-23.21M288.47%35.48M1,492.89%15.67M-292.52%-18.82M19.85%984K1,350.82%9.74M198.72%9.78M--821K
Operating profit 52.90%-244.58M10.97%-975.14M-18.06%-519.26M-98.53%-1.1B-90.06%-439.82M-248.23%-551.7M-374.56%-231.41M-374.83%-111.66M-128.71%-158.43M-48.76M
Financing cost -14.04%-9.83M-63.56%-18.59M-55.15%-8.62M-109.13%-11.37M-688.37%-5.56M88.95%-5.44M-247.29%-705K-162.50%-273K-9,163.09%-49.19M---203K
Special items of earning before tax -51.59%-25.54M24.84%-29.8M7.04%-16.85M-44.85%-39.66M-73.54%-18.12M-1,534.45%-27.38M---10.44M---2.84M---1.68M----
Earning before tax 48.61%-279.95M10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M
After-tax profit from continuing operations 48.61%-279.95M10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M
Earning after tax 48.61%-279.95M10.71%-1.02B-17.53%-544.73M-96.11%-1.15B-91.09%-463.5M-179.28%-584.51M-395.36%-242.56M-385.91%-114.77M-199.84%-209.29M-48.97M
Minority profit 51.25%-2.79M-75.30%-11.36M-28.59%-5.72M-308.45%-6.48M-647.73%-4.45M-281.25%-1.59M---595K---362K---416K----
Profit attributable to shareholders 48.58%-277.16M11.20%-1.01B-17.42%-539.01M-95.53%-1.14B-89.72%-459.05M-179.08%-582.92M-394.15%-241.97M-384.37%-114.41M-199.24%-208.87M-48.97M
Basic earnings per share 48.21%-0.2910.92%-1.06-16.67%-0.56-88.89%-1.19-77.78%-0.48-133.33%-0.63-285.71%-0.27-333.33%-0.13-145.45%-0.27-0.07
Diluted earnings per share 48.21%-0.2910.92%-1.06-16.67%-0.56-88.89%-1.19-77.78%-0.48-133.33%-0.63-285.71%-0.27-333.33%-0.13-145.45%-0.27-0.07
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified Opinion----Unqualified Opinion--
Auditor --KPMG (Special General Partnership)--KPMG (Special General Partnership)--KPMG (Special General Partnership)----KPMG--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
% Chg

No Data